WANDA BEARING
920002
CG MED EQUIP.
838810
SUZHOUBEARING
430418
COCYBER
835207
Guangdong Create Century Intelligent Equipment Group Corporation
300083
CN Stock MarketDetailed Quotes
603168 Zhejiang Shapuaisi Pharmaceutical
- 7.00
- +0.14+2.04%
Market Closed Feb 26 15:00 CST
2.63BMarket Cap-30.97P/E (TTM)
7.01High6.88Low54.34KlotVolume6.90Open6.86Pre Close37.85MTurnover1.69%Turnover Ratio102.94P/E (Static)375.93MShares11.1852wk High1.56P/B2.26BFloat Cap5.9052wk Low7.55Limit Up322.59MShs Float55.88Historical High6.17Limit Down1.90%Amplitude4.94Historical Low0.02Dividend TTM6.96Avg Price22.13KlotAsk0.30%Div YieldTTM100Lot Size30.75KlotBid
Zhejiang Shapuaisi Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -27.95%359.4M | -30.65%236.85M | -15.02%137.83M | 17.37%644.97M | 20.36%498.79M | 21.94%341.55M | 8.59%162.2M | -12.74%549.54M | -12.41%414.41M | -11.57%280.09M |
| Operating revenue | -27.95%359.4M | -30.65%236.85M | -15.02%137.83M | 17.37%644.97M | 20.36%498.79M | 21.94%341.55M | 8.59%162.2M | -12.74%549.54M | -12.41%414.41M | -11.57%280.09M |
| Other operating revenue | ---- | 180.79%12.4M | ---- | -29.03%6.94M | ---- | -8.62%4.42M | ---- | 351.89%9.77M | ---- | -17.35%4.83M |
| Total operating cost | -9.50%401.14M | -7.23%258.89M | 2.91%133.51M | 25.23%629.24M | 19.66%443.24M | 12.47%279.08M | 1.34%129.73M | -13.41%502.47M | -13.07%370.41M | -11.95%248.13M |
| Operating cost | -18.40%179.39M | -21.60%114.98M | -8.10%67.08M | 24.59%283.93M | 27.09%219.84M | 29.27%146.66M | 33.62%72.99M | 1.44%227.89M | 3.78%172.97M | -11.38%113.45M |
| Operating tax surcharges | -5.02%4.49M | -13.74%2.8M | -27.61%1.43M | 35.93%8.08M | 1.17%4.73M | -0.79%3.24M | 15.67%1.98M | -27.86%5.94M | -23.11%4.67M | -14.54%3.27M |
| Operating expense | -8.39%65.23M | 9.33%42.59M | 24.55%21.78M | 45.09%135.33M | -5.86%71.2M | -16.33%38.95M | -33.54%17.48M | -19.84%93.28M | -7.19%75.63M | -19.70%46.56M |
| Administration expense | 6.18%102.44M | -3.89%60.25M | 10.46%30.61M | 16.47%136.27M | 22.27%96.47M | 13.91%62.69M | 9.52%27.71M | -12.02%117M | -17.64%78.9M | -4.89%55.04M |
| Financial expense | 3,010.55%4.83M | 432.37%2.7M | 175.51%482.45K | 194.82%1.19M | 116.86%155.33K | -166.75%-811.09K | -14.03%-638.92K | 70.09%-1.25M | 77.70%-921.06K | 89.18%-304.07K |
| -Interest expense (Financial expense) | 134.19%6.05M | 185.31%3.75M | --1.21M | 180.86%4.61M | --2.58M | --1.31M | ---- | 113.86%1.64M | ---- | ---- |
| -Interest Income (Financial expense) | 48.10%-1.35M | 40.52%-1.34M | -0.49%-948.45K | -20.30%-3.7M | -14.95%-2.59M | -88.78%-2.25M | 1.64%-943.86K | 39.15%-3.08M | 50.57%-2.26M | 58.70%-1.19M |
| Research and development | -11.96%44.77M | 25.55%35.58M | 18.88%12.13M | 8.11%64.45M | 29.85%50.85M | -5.91%28.34M | -50.53%10.2M | -41.68%59.61M | -51.19%39.16M | -18.44%30.12M |
| Credit Impairment Loss | -192.21%-3.32M | -119.73%-596.24K | 214.13%558.57K | 171.51%3.09M | 354.26%3.6M | 595.49%3.02M | -19.95%-489.42K | -151.37%-4.32M | -1,938.75%-1.41M | -278.38%-609.77K |
| Asset Impairment Loss | -184.25%-801.03K | -224.12%-1.47M | 190.31%310.46K | -27.97%-14.52M | 228.63%950.75K | 275.59%1.19M | ---343.77K | -472.12%-11.34M | 82.74%-739.15K | 107.38%315.98K |
| Other net revenue | 6.21%20.43M | -50.39%2.62M | 257.35%1.69M | -26.25%6.31M | 12.10%19.23M | -65.45%5.29M | -107.35%-1.08M | 57.40%8.56M | 15,522.46%17.16M | 1,128.69%15.3M |
| Fair value change income | -107.87%-34K | -107.87%-34K | ---34K | -87.16%1.19M | 15.36%431.96K | 26.32%431.96K | ---- | 251.42%9.27M | --374.46K | --341.96K |
| Invest income | 58.02%21.97M | 663.72%2.61M | 143.20%172.04K | 694.21%13.71M | 660.95%13.9M | 122.68%341.53K | 52.49%-398.2K | -150.49%-2.31M | -33.27%1.83M | -158.77%-1.51M |
| -Including: Investment income associates | -43.17%2.36M | 194.30%2.96M | 452.78%444.2K | 228.00%2.79M | --4.16M | --1M | --80.36K | ---2.18M | ---- | ---- |
| Asset deal income | -30.01%17.79K | 127.79%17.79K | --17.79K | -99.68%51.04K | -99.84%25.41K | -99.95%7.81K | ---- | 217,692.60%15.86M | 220,570.31%16.07M | 83,525.33%16.07M |
| Other revenue | 689.72%2.6M | 603.93%2.1M | 333.05%669.43K | 99.86%2.79M | -68.36%328.88K | -57.16%298.38K | 1,624.16%154.59K | -28.04%1.4M | -40.02%1.04M | 68.34%696.59K |
| Operating profit | -128.49%-21.31M | -128.65%-19.41M | -80.83%6.02M | -60.38%22.04M | 22.28%74.79M | 43.35%67.76M | -12.80%31.39M | 1.27%55.62M | 29.87%61.16M | 41.36%47.27M |
| Add:Non operating Income | -98.71%191.44K | -98.74%186.44K | 707.66%8.09K | 147,289.18%15.04M | 352,749.99%14.84M | 673,707,690.91%14.82M | -87.79%1K | -80.74%10.21K | -84.17%4.2K | -99.99%2.2 |
| Less:Non operating expense | -31.27%1.87M | -45.43%1.44M | -91.75%184.11K | 147.24%4M | 454.75%2.73M | 719.69%2.64M | 801.99%2.23M | -73.46%1.62M | -88.23%491.34K | -70.87%321.51K |
| Total profit | -126.46%-22.99M | -125.85%-20.66M | -79.97%5.84M | -38.76%33.08M | 43.22%86.9M | 70.29%79.95M | -18.45%29.16M | 10.51%54.01M | 41.28%60.67M | 45.08%46.95M |
| Less:Income tax cost | -29.71%5.41M | -38.89%4.16M | -76.49%1.6M | -13.89%7.97M | -50.05%7.7M | -39.91%6.8M | -16.31%6.79M | -29.94%9.26M | 126.77%15.41M | 109.33%11.32M |
| Net profit | -135.86%-28.4M | -133.93%-24.82M | -81.03%4.25M | -43.90%25.1M | 74.99%79.2M | 105.29%73.15M | -19.08%22.38M | 25.51%44.75M | 25.21%45.26M | 32.19%35.63M |
| Net profit from continuing operation | -135.86%-28.4M | -133.93%-24.82M | -81.03%4.25M | -45.18%25.1M | 70.33%79.2M | 98.40%73.15M | -22.54%22.38M | -9.19%45.79M | 28.63%46.5M | 36.78%36.87M |
| Net income from discontinuing operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 92.96%-1.04M | ---1.24M | ---1.24M |
| Less:Minority Profit | 1,045.11%2.35M | 48.48%-102.61K | 65.78%-51.05K | -35,333.41%-303.41K | ---249.14K | ---199.17K | ---149.19K | --861.13 | ---- | ---- |
| Net profit of parent company owners | -138.71%-30.76M | -133.70%-24.72M | -80.93%4.3M | -43.23%25.41M | 75.54%79.45M | 105.85%73.35M | -18.54%22.53M | 25.51%44.75M | 25.21%45.26M | 32.19%35.63M |
| Earning per share | ||||||||||
| Basic earning per share | -138.10%-0.08 | -135.00%-0.07 | -83.33%0.01 | -50.00%0.07 | 50.00%0.21 | 81.82%0.2 | -33.33%0.06 | 27.27%0.14 | 27.27%0.14 | 37.50%0.11 |
| Diluted earning per share | -138.10%-0.08 | -135.00%-0.07 | -83.33%0.01 | -50.00%0.07 | 50.00%0.21 | 81.82%0.2 | -33.33%0.06 | 27.27%0.14 | 27.27%0.14 | 37.50%0.11 |
| Other composite income | ||||||||||
| Total composite income | -135.86%-28.4M | -133.93%-24.82M | -81.03%4.25M | -43.90%25.1M | 74.99%79.2M | 105.29%73.15M | -19.08%22.38M | 25.51%44.75M | 25.21%45.26M | 32.19%35.63M |
| Total composite income of parent company owners | -138.71%-30.76M | -133.70%-24.72M | -80.93%4.3M | -43.23%25.41M | 75.54%79.45M | 105.85%73.35M | -18.54%22.53M | 25.51%44.75M | 25.21%45.26M | 32.19%35.63M |
| Total composite income of minority owners | 1,045.11%2.35M | 48.48%-102.61K | 65.78%-51.05K | -35,333.41%-303.41K | ---249.14K | ---199.17K | ---149.19K | --861.13 | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
